Featured Articles

  1. A Lean, Agile Business Model To Deliver High-Quality Oncologic Treatments 12/11/2023

    No two journeys through the drug pipeline are the same; the ability to leverage a variety of approaches for different products is what sets one lean biotech company apart.

  2. A Tale Of Two Brothers: The Abpro Founders 12/11/2023

    By founding their latest venture, Abpro, Ian and Eugene Chan are using their synergistic skillsets in business and medicine to rapidly generate antibodies that treat cancer and autoimmune diseases.

  3. Welcoming The "Era Of ADCs" 12/5/2023

    Dr. Loretta Itri sat down to explore the promise of TRODELVY®️ and other antibody-drug conjugates as transformative treatments for a range of malignancies and intractable diseases.

  4. In Silico Approaches Towards Automated Biomanufacturing 11/6/2023

    As part of MSAT, in silico approaches such as mechanistic modeling can be used to support and facilitate several activities in the production of biopharmaceuticals at all scales.

  5. Bioprocessing 4.0: Digital Transformation Of Process Development 11/6/2023

    Discover how, in combination with artificial intelligence, augmented reality, robotics, and digital twins, biopharma 4.0 is changing legacy concepts from the ground up.

  6. Simulation Gets Therapies To Patients Faster And Smarter 11/6/2023

    Access to digital solutions like in silico software products that help to decrease therapeutic time to market and get lifesaving drugs to patients faster and smarter remains a challenge in biopharma.

  7. In Silico Optimization Of A Multimodal Chromatography mAb Polishing Step 10/13/2023

    Achieve process optimization in the multimodal chromatography polishing step of monoclonal antibody manufacturing, doubling process productivity with just six calibration experiments.

  8. Continuous Processing For Enhanced Monoclonal Antibody Production 9/14/2023

    mAbs have only recently been leveraged for advanced bioprocessing techniques. Explore highlights from a webinar where experts discussed their unique collaboration for the continuous processing of mAbs.

  9. Biopharma Manufacturing For Advanced Therapies: A Panel Discussion 9/1/2023

    Explore highlights from a panel discussion focused on improving biomanufacturing processes to help ensure the next generation of advanced therapies is both accessible and affordable to patients.

  10. Enhancing Security Of Supply Of Cell Culture Media With Single-Use Bags 9/1/2023

    Biopharma manufacturers continue to face a challenging supply and demand landscape. Learn how Cytiva secured its single-use bag supply with in-house manufacturing of liquid media bags.